BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7182819)

  • 1. [Spirographic indicators and theophylline levels in the blood and saliva after oral administration of 2 euphylline preparations in patients with reversible bronchial obstruction].
    Biernacki W; Bestry-Fus I; Figielski G
    Pneumonol Pol; 1982 Dec; 50(12):647-52. PubMed ID: 7182819
    [No Abstract]   [Full Text] [Related]  

  • 2. [Broncholytic effect of pencardin in chronic bronchial asthma].
    Bestry-Fus I
    Pneumonol Pol; 1981 Jan; 49(1):43-7. PubMed ID: 7027193
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of misoprostol, a synthetic equivalent of prostaglandin E1, on bronchodilation in bronchial spasm].
    Marcisz C; Jonderko G; Gina R; Szkliniarz J
    Pol Tyg Lek; 1992 Aug 18-31; 47(34-35):733-4. PubMed ID: 1488359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A dose-concentration relationship study in different dosage regimens for theophylline preparations: intravenous for euphylline and peroral for prolonged-action forms].
    Tsoĭ AN; Bogovskiĭ BP; Gavrilenko LN; Kushkenbaeva BE; Kukes VG
    Ter Arkh; 1990; 62(9):22-5. PubMed ID: 2281401
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral aminophylline and dikydroxypropyl theophylline in reversible obstructive airway disease: a single-dose, double-blind, crossover comparison.
    Hudson LD; Tyler ML; Petty TL
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):367-72. PubMed ID: 4198297
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacokinetic research on theophylline].
    Tsoĭ AN; Gneushev ET; Bogovskiĭ BP; Kaz'mina EM; Abrosimov AG
    Farmakol Toksikol; 1987; 50(1):89-91. PubMed ID: 3556561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bronchospasmolytic effectiveness of controlled drug combinations].
    Forche G; Zenker G; Harnoncourt K
    Wien Med Wochenschr; 1986 May; 136(9):213-8. PubMed ID: 3739357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of bronchospasmolytics in the asthmatic.
    Aepli R
    Helv Med Acta; 1969 Mar; 34(6):517-31. PubMed ID: 4888561
    [No Abstract]   [Full Text] [Related]  

  • 9. [The relationship of the theophylline concentration in the saliva and the blood serum in patients with a broncho-obstructive syndrome].
    Tsoĭ AN; Gavrilenko LN; Kushkenbaeva BE; Kukes VG
    Ter Arkh; 1994; 66(8):42-4. PubMed ID: 7985153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of microencapsulation on the pharmacological activity of theophylline and euphylline].
    Andreeva IN; Saraf AS; Makarov VA
    Farmakol Toksikol; 1991; 54(5):27-9. PubMed ID: 1800140
    [No Abstract]   [Full Text] [Related]  

  • 11. Slow release salbutamol and Tedral in the treatment of reversible airways obstruction.
    Lal S; Bhalla KK; Davey AJ
    Postgrad Med J; 1971 Mar; 47():Suppl:89-92. PubMed ID: 4929401
    [No Abstract]   [Full Text] [Related]  

  • 12. [Early replacement of intravenous aminophylline administration with oral theophylline in treating acute exacerbation of asthma].
    Ono Y; Kondo T; Tanigaki T; Syouyama Y; Moue Y; Kamiya U; Tazaki G; Ohta Y
    Nihon Kokyuki Gakkai Zasshi; 2001 Feb; 39(2):75-81. PubMed ID: 11321830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum levels of theophylline and rate of administration by intravenous route].
    Cukier A; Santos SR; Terra Filho M; Fiss E; Silva GM; Saad E; Romeiro Neto M; Vargas FS
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(3):115-7. PubMed ID: 3454044
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical efficiency of neobiphyllineR-studies on lung function and serum levels after rectal application of a combination of methyl-xanthines.
    Loytved G; Werdermann K; Jorde W; Petro W
    Agents Actions Suppl; 1983; 13():131-40. PubMed ID: 6346832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of oral theophylline on bronchospasm.
    Howard LA
    J Asthma Res; 1971 Mar; 8(3):111-4. PubMed ID: 5581809
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of the bronchospastic syndrome].
    Kazanbiev NK; Magomedov AZ; Minkailov KM
    Sov Med; 1986; (10):51-4. PubMed ID: 3544241
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of bronchodilating and metabolic effects of intravenous aminophylline and subcutaneous epinephrine individually and in combination in patients with bronchial asthma].
    Kihara N; Makino S
    Arerugi; 1982; 31(7):390-400. PubMed ID: 6295342
    [No Abstract]   [Full Text] [Related]  

  • 18. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of oral sustained released bronchodilator in stable asthmatics.
    Koyande DN; Shah SP; Hingorani M; Ailani RK; Haran A; Kadge KM
    Indian J Chest Dis Allied Sci; 1993; 35(2):51-7. PubMed ID: 8258465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spirographic results with decloxizine].
    Vaerenberg C
    Acta Tuberc Pneumol Belg; 1968; 59(4):541-8. PubMed ID: 5739744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.